RxDoctor Payments Data

Chong Kim, MD

Interventional Pain Medicine · Cleveland, OHNPI 1467508663

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 72.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $367 and has fallen 56.1% since, to $161 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.

$1,263in general payments, 2019–2025

Across 12 payments — averaging $105.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$912
  • Medtronic$197
  • Nevro Corp.$131
  • Vertex$14
  • Relievant Medsystems, Inc.$9
$5,518in research payments, 2019–2025

Across 2 payments — averaging $2758.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertiflex, Inc.$6K
  • Saluda Medical Americas, Inc.$18

What the payments were for

  • Food & beverage$1,263100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott7$912
Medtronic(2 entities)2$197
Nevro Corp.1$131
Vertex1$14
Relievant Medsystems, Inc.1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,263 in reported general payments places this provider in the 10th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$55,774
Medicare patients
280
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin28$749
Lidocaine12$718
Morphine Sulfate14$443
Acetaminophen-CodeineAcetaminophen With Codeine14$363
Gabapentin39$318
Morphine Sulfate ErMorphine Sulfate11$313
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$205
Cyclobenzaprine Hcl15$153
Diclofenac Sodium11$140
Oxycodone Hcl12$136
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$136
Tramadol Hcl21$131
Tizanidine Hcl11$79
Meloxicam11$57
Diazepam11$5

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →